We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tyratech (DI) | LSE:TYRU | London | Ordinary Share | COM SHS USD0.001 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.00 | 2.80 | 3.20 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
31/8/2017 15:39 | and we might hear about corporate restructuring | corrientes | |
31/8/2017 15:32 | just looked backed to see I sold tyru at 1.6 in may and bought tyr with the cash.( I think TYR plummeted on 24th of may)Today I added both and was able to buy back the tyru at 1.2p. I am bullish about this stock now we know the results will be satisfactory. | ashtree2 | |
31/8/2017 15:15 | Curious that people are now buying TYR rather than TYRU. Yes I know they are cheaper but that has always been the case. For years TYRU turnover has been far higher than TYR despite this discount. Nobby | nobbygnome | |
31/8/2017 14:05 | after my buy the price to buy went up but to sell unchanged. | ashtree2 | |
31/8/2017 13:55 | Ta very much BIKWIK. TYR up for the third straight session so hopefully TYRU will soon follow. For that to happen we need some volume though. | michaelsadvfn | |
31/8/2017 11:22 | Chart of TYRU to go along with my comments above: free stock charts from uk.advfn.com | bikwik | |
31/8/2017 11:01 | Very true clocktower,yet of interest,hopefully,t | mudbath | |
31/8/2017 10:13 | Thank you for that mud, well worth keeping in mind but not definitive proof of anything, in fact the word "climactic" is one that might be a cause for concern imo. | clocktower | |
31/8/2017 09:37 | BIKWIK, who commands a good following for his chartist views,had these observations to make(at my request)regarding the medium term past trajectory (and future potential) for the Tyratech share price . "TYRU - This is a log chart, linear would be too squashed at the bottom. Also percentage moves more relevant so easier to see here. The vertical purple lines are cycles - about 19-20 weeks between. They sometimes go out of sync - as this one did at the 23.75p rally high! They sometimes return, seems to be doing that here. So we may have seen the low, no guarantees of course! As each candle is a month, the latest is almost finished, so one more day to go! Assuming it stays around or above current price - we have a bull hammer! We had one at the 2.125p low and a 6 week (albeit choppy) rally followed. The two black boundary lines over the last 4 years or so are converging and down sloping, so essentially a bullish falling wedge and once an upside breakout of the upper one occurs then a significant uptrend should follow. (Not yet though!!). The break under the lower line this month suspiciously looks like a false downward break - though it obviously hasn't done it yet, but is often a precursor for the real move to follow the other way! First a break of the steeper and shorter 15 month downtrend is needed to turn the outlook bullish. A close over (monthly basis) 1.575p would do it (also halfway of June's 1.875p-1.375p black candle). The whole pattern since the first purple line has a three cycle look to it - which in this case looks like a large head and shoulders pattern (which should turn out to be a base - because if it was a top it would suggest a minus share price - i.e bust!). THe initial move down from 23.75p to 4.375p was a drop of 81.57%. The same percentage projection down from 4.375p would give 0.806p - we have seen a low of 0.925p, reasonably close. Lastly on the daily chart the recent drop looks quite steep and has a climactic look about it. Well that's it, hope that helps!" I hope that for some,BIKWIK's thoughts will prove to be of interest,even though I appreciate that charts are not everyone's "bag". | mudbath | |
30/8/2017 12:21 | MM's now bidding 0.9p for TYR. Up yesterday & up again today fwiw. | michaelsadvfn | |
30/8/2017 10:41 | One would think so. You may be correct mudbath re. not needing corporate action for a rise. Perhaps the fact Tyratech are pretty close to break-even might tempt a few once the results have been digested. No debt, cash in the bank, no chance of a placing(on current trading), pared losses. Plenty to go for. | michaelsadvfn | |
30/8/2017 09:59 | As opposed to Tyratech, how many AIM micro caps have recently secured an agreement for a global multi national to develop ,commercialize and fund the reach of its nature-derived technologies whilst also retaining the right to use any new IP in its own fields (personal care and animal health)? The promise of future royalties and an upfront sweetener of US$500k are additional icing on the TYRU cake. With preliminary results due on Sept 12th(which we know are satisfactory),a pending sale of IP by Mondelez,and the prospect imminent strategic corporate action to "unlock the full value of the Company for the shareholders",then the trajectory of the Tyratech share price might just continue in the upward direction that has recently become visible. In other words......GOING UP !! | mudbath | |
30/8/2017 09:05 | Phil's been waiting 4 years to come out with that tired old predictable BB comment, having been sitting on a loss all that time no doubt ... And no it ain't down to investing prowess, usually just luck where AIM is concerned. | al h | |
30/8/2017 08:59 | Pity you escaped from one, and didn't your mum tell you not to tempt fate? | michaelsadvfn | |
30/8/2017 08:25 | Hi mudbath - pity you didn't agree with me and stay with ZOO! Rather than this flea pit. | philjeans | |
25/8/2017 12:00 | I am not too sure that corporate action alone will be needed for an upward re rate,as I believe that the upcoming results will provide some encouragement. Taken in the context of the last half dozen update and result statements, Bruno Jactel's recent update summary that, "Overall trading remains satisfactory and the Company expects to report results in-line with current market expectations." is verging on bullish. As you say- no "howevers" ! | mudbath | |
25/8/2017 11:25 | I'm not surprised they're prepared to take TYR stock at that price as it values the company at under £3m. They aren't notorious for taking risks. I'm beginning to come to the conclusion that only some sort of corporate action will have any effect on the share price. 2x 2016 net Vamousse profits clearly isn't garnering any interest whatsoever. | michaelsadvfn | |
25/8/2017 11:11 | Our seller of TYRU shares has returned,unfortunate On a more positive note,they are bidding,at a premium, for the TYR stock in parcels of 1,000,000 and above. | mudbath | |
25/8/2017 09:28 | A rather pertinent question...who is aware of the ninesights website and accesses it on a regular basis? I'd have thought they'd have had more chance of success by being proactive. They obviously know who it would be attractive to so why not approach those companies directly? They have extended the closing date at least 3 times so I think we can assume it won't lead to anything, not via ninesights at any rate. | michaelsadvfn | |
25/8/2017 09:01 | Mondelez continues to solicit expressions of interest with the new closing date pushed forward to Sept 22nd 2017. (Mondelēz International and TyraTech have invested significant time and effort into the collaborative development of a parasite prevention technology targeted to reduce the impact of these intestinal parasites as a public health issue. The high value technology solution developed by Mondelēz International and TyraTech is designed to be safe, natural and non-toxic. It effectively kills intestinal parasites and is deployable as a daily maintenance solution through several platforms and has potential applications for both human and animal health applications..) I would have thought that the "major global consumer products company" involved via the July Evance agreement would have registered an interest. Maybe they have ! | mudbath | |
24/8/2017 15:31 | Bruno Jactel stated that he did not feel that Evance agreement would be "transformational" in terms of profitability. Neither did he say that the deal would have little impact;rather his view was that TyraTech would benefit from this agreement via three specific avenues,each in its own right promising to support the development of its IP and promote future profitability. I have to agree with Chinese Investor that prospects look good. | mudbath | |
24/8/2017 14:36 | Looking Good ! | chinese investor | |
24/8/2017 09:25 | PS plus of course the $500k from Envance announced recently means the cash position should be reasonable as well! | nobbygnome | |
24/8/2017 09:24 | Well if the recently announced License Agreement with a major global consumer products company to develop and commercialize a range of pest control household products based on TyraTech's nature-derived technologies represents "failure",then we shareholders have no worries. I remain surprised that the agreement attracted so little in the way of positive comment or indeed was not reflected in an upward movement of the Tyratech share price,for there were many very attractive ongoing benefits accruing to TYRU within its terms. "TyraTech Inc. (AIM: TYR, and TYRU), a life sciences company focused on nature-derived insect and parasite control products, today announces that Envance Technologies LLC (Envance) has entered a Joint Development and License Agreement (the "Agreement") with a major global consumer products company (the "Corporation) to develop and commercialize a range of pest control household products based on TyraTech's nature-derived technologies. Envance is a joint venture between American Vanguard Corporation (NYSE: AVD) (AMVAC) which holds a 86.67% interest and TyraTech which holds 13.33%. AMVAC is also a 15.15% shareholder in TyraTech. The Agreement sub-licenses Envance's existing rights to TyraTech's intellectual property ("IP") and knowhow with applications in the consumer household pest control sector to the Corporation. The Agreement specifically excludes personal care products, which are the sole property of TyraTech, such as the Vamousse® range of head lice treatments; Guardian™ personal insect repellants; as well as Animal Health applications. TyraTech will benefit from this agreement in several ways. First, all parties will share technology and expertise in the development of new products for use in controlling pests in the home environment, and new intellectual property created will be jointly owned. Significantly, TyraTech will gain the right to use the new IP in its own fields (personal care and animal health). Second, TyraTech will be entitled to a small share of the profit of Envance, derived from the royalties on the Corporation's net sales of these products. Separately, in recognition of the addition of further IP in the same household sector, Envance will pay TyraTech associated royalties and an additional upfront cash fee of $500,000 which will be used to fund normal working capital. Third, it is envisaged that TyraTech will also be involved in the development of the new products in the first few years of the Agreement, which is being fully funded by Envance. TyraTech will receive a fee in relation to research and development services in line with the terms of its existing agreement with Envance." Tyratech appears in a much stronger position than that which it experienced some 12 months ago,yet the share price languishes 50% below the level seen in August 2016. Maybe then there is some benefit to be extracted by investing at current levels.(TYR and TYRU) | mudbath | |
24/8/2017 09:22 | So assuming 'double digit' growth turnover for the year will be £7 million+. The market cap even after the rise today is about £3.8 million so the company is only valued at slightly above a half times turnover. Yes they need funds for the animal health product development but clearly that valuation is completely ridiculous. As we will no doubt discover shortly from the business review, Vamousse alone must be valued at more than double the market cap. The update today effectively tells us that there are no shocks in store so the price has to rise from here IMHO. Nobby | nobbygnome |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions